Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma
出版年份 2022 全文链接
标题
Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma
作者
关键词
-
出版物
Journal of Immunology Research
Volume 2022, Issue -, Pages 1-40
出版商
Hindawi Limited
发表日期
2022-10-15
DOI
10.1155/2022/2756611
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of Active Bronchioalveolar Stem Cells as the Cell-of-Origin in Lung Adenocarcinoma
- (2022) Huijing Yin et al. CANCER RESEARCH
- Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis
- (2022) Peng Cao et al. DISEASE MARKERS
- Preoperative and Postoperative Systemic Therapy for Operable Non–Small-Cell Lung Cancer
- (2022) Jamie E. Chaft et al. JOURNAL OF CLINICAL ONCOLOGY
- α-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer
- (2022) Chia-Hao Tung et al. Theranostics
- The Influence of Cancer Stem Cells on the Risk of Relapse in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Prospective Cohort Study
- (2022) Valentina Masciale et al. Stem Cells Translational Medicine
- Low‐dose computed tomography lung cancer screening: Clinical evidence and implementation research
- (2022) Harriet L. Lancaster et al. JOURNAL OF INTERNAL MEDICINE
- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC
- (2022) Xing Niu et al. SEMINARS IN CANCER BIOLOGY
- A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma
- (2022) Zilong Bian et al. Genes
- A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
- (2022) Yinliang Lu et al. Frontiers in Genetics
- Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma
- (2022) Xi Chen et al. Frontiers in Oncology
- Identification and Validation of Apparent Imbalanced Epi-lncRNAs Prognostic Model Based on Multi-Omics Data in Pancreatic Cancer
- (2022) Mujing Ke Frontiers in Molecular Biosciences
- A novel EHD1/CD44/Hippo/SP1 positive feedback loop potentiates stemness and metastasis in lung adenocarcinoma
- (2022) Yuechao Liu et al. Clinical and Translational Medicine
- A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
- (2022) Genhao Zhang et al. Scientific Reports
- Integrated Analysis of a Ferroptosis-Related LncRNA Signature for Evaluating the Prognosis of Patients with Colorectal Cancer
- (2022) Shaohua Xu et al. Genes
- A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
- (2022) Mingyi Yang et al. Frontiers in Immunology
- Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
- (2022) Miaorong Xu et al. Frontiers in Oncology
- A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma
- (2021) Zaoqu Liu et al. Journal of Translational Medicine
- Immune Resistance in Lung Adenocarcinoma
- (2021) Magda Spella et al. Cancers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of autophagy‐related long non‐coding RNA prognostic signature for breast cancer
- (2021) Qianxue Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Progress in understanding the role of lncRNA in programmed cell death
- (2021) Na Jiang et al. Cell Death Discovery
- Hesitancy around low dose CT screening for lung cancer
- (2021) J.L. Dickson et al. ANNALS OF ONCOLOGY
- The Role of Long Noncoding RNA AL161431.1 in the Development and Progression of Pancreatic Cancer
- (2021) Gang Ma et al. Frontiers in Oncology
- A Novel Prognostic Model Based on Autophagy-Related Long Non-Coding RNAs for Clear Cell Renal Cell Carcinoma
- (2021) Xinyuan Li et al. Frontiers in Oncology
- Seven autophagy-related lncRNAs are associated with the tumor immune microenvironment in predicting survival risk of nonsmall cell lung cancer
- (2021) Huihui Jiang et al. Briefings in Functional Genomics
- Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer
- (2021) Wenchang Lv et al. Frontiers in Oncology
- The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
- (2021) Enhao Wang et al. Frontiers in Cell and Developmental Biology
- The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
- (2021) Andrew G. Nicholson et al. Journal of Thoracic Oncology
- m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer
- (2020) Bo Zhang et al. Molecular Cancer
- Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma
- (2020) Tiffany Tsang et al. NATURE CELL BIOLOGY
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
- (2020) Lynette M. Sholl et al. Journal of Thoracic Oncology
- Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
- (2020) Xiaoying Li et al. Journal of Translational Medicine
- Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
- (2020) Hao Sun et al. EBioMedicine
- Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma
- (2020) Giuseppe Lamberti et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature
- (2020) Wei Ma et al. Journal of Translational Medicine
- The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
- (2020) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
- (2019) Francesca Finotello et al. Genome Medicine
- Circulating essential metals and lung cancer: Risk assessment and potential molecular effects
- (2019) Yansen Bai et al. ENVIRONMENT INTERNATIONAL
- Statistical predictions with glmnet
- (2019) Solveig Engebretsen et al. Clinical Epigenetics
- Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
- (2018) Tathiane M. Malta et al. CELL
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- Association between serum copper levels and lung cancer risk: A meta-analysis
- (2018) Xiaping Zhang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data
- (2017) Julien Racle et al. eLife
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
- (2014) Paul Geeleher et al. PLoS One
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now